Taysha Gene Therapies (TSHA) Share-based Compensation (2020 - 2026)
Taysha Gene Therapies' Share-based Compensation came in at $5.81 million for Q2 2026, up 82.1% from $3.19 million a year earlier and up 4.7% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Taysha Gene Therapies reported Share-based Compensation of $18.17 million, up 39.2% year-over-year; for FY2025, it came in at $13.3 million, up 1.5% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of 31.7% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $13.1 million in FY2024 (+65.8%), $7.91 million in FY2023 (-56.2%), $18.04 million in FY2022 (-0.8%) and $18.18 million in FY2021 (+442.2%).
- The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q4 2020.
- Year-over-year, Share-based Compensation has increased for three consecutive quarters, with growth averaging 35.6% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q4 2021 (growth of 146.2%), and the weakest in Q1 2023 (a decline of 68.6%).
- Business Quant data shows TSHA's Share-based Compensation at $5.55 million (Q1 2026), $3.53 million (Q4 2025) and $3.29 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Taysha Gene Therapies | 1.52 Bn | 173.19 Mn | - | 5.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.81 Mn |
| Mar 31, 2026 | 5.55 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 3.29 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Mar 31, 2025 | 3.29 Mn |
| Dec 31, 2024 | 3.22 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | 2.22 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 4.10 Mn |
| Sep 30, 2022 | 4.47 Mn |
| Jun 30, 2022 | 4.14 Mn |
| Mar 31, 2022 | 5.33 Mn |
| Dec 31, 2021 | 4.96 Mn |
| Sep 30, 2021 | 5.09 Mn |
API Access
Taysha Gene Therapies Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();